Requadt Scott 4
4 · Talaris Therapeutics, Inc. · Filed Jul 6, 2023
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Tax Payment
Common Stock
2023-07-03$3.08/sh−11,786$36,301→ 578,403 total
Holdings
- 449,766(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The restricted stock units ("RSUs") were granted to the Reporting Person by the issuer under the Issuer's 2021 Stock Option and Incentive Plan on September 10, 2022. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest as to 50% of the underlying shares on July 1, 2023 and the remaining 50% on July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. This transaction reflects the sufficient shares sold to pay applicable income taxes related to the 50% vesting on July 1, 2023.
- [F2]These shares are held by Requadt Family Limited Partnership. The reporting person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.